Description
Specification: repaglinide 0.5mg×30 tablets, repaglinide
0.5mg×60 tablets.
Indications:
It is used for type 2 diabetes (non-insulin-dependent) patients whose
hyperglycemia cannot be effectively controlled by diet control, weight loss and
exercise. When metformin alone cannot effectively control hyperglycemia,
Repaglinide tablets can be combined with metformin. Treatment should start from
the adjuvant treatment of diet control and exercise to reduce blood sugar
during meals.
Specifications of Repaglinide Tablets: 0.5mg
